It is normal practice in other industries and can only help their reputations to get follow up work.
As a company, would you go back automatically to those CRO's for future trials knowing that they don't care much about timely completing of contracts?
In the Biotech sector, speed is the ultimate to bat any competitors.
It is normal practice in other industries and can only help...
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $43.30M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.0¢ | 4.8¢ | $13.69K | 278.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 50000 | 4.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 46070 | 1 |
View Market Depth
| Last trade - 15.37pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
5.0¢ |
Change
-0.002 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 4.9¢ | 5.0¢ | 4.9¢ | 61814 | ||
| Last updated 13.21pm 17/06/2024 ? | |||||
| BIT (ASX) Chart |
